pembrolizumab
merck
['keytruda', '$mrk']
$mrk ilt3 data: no monorx activity, but myositis revealed to be in keytruda combo. #asco22 data of relevance to $jnce $agen $agm &amp; others. via 
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.